Literature DB >> 16142573

Health related quality of life in patients with chronic kidney disease.

Kamyar Kalantar-Zadeh1, Mark Unruh.   

Abstract

Monitoring a patient's functional status and the subjective state of well being as it related to health condition, together known as health related quality of life (HRQOL) measurements, is of particular importance in patients with chronic kidney disease (CKD) including those with end stage renal disease (ESRD). The concept of quality of life in dialysis has evolved since the inception of renal replacement therapy from simple survival to enjoying a certain level of well being. The measurement of dialysis outcomes have paralleled the improvement in the delivery of renal replacement therapy progressing from level of functioning, symptom checklists, multi dimensional well being, and moving perhaps to more patient centered quality of life. HRQOL domains have been strongly associated with objective patient outcomes. The self reported physical functioning and mental well being correlate with serum albumin and body composition measures. The ability of those on hemodialysis to self administer questionnaires is a barrier to the widespread use of multidimensional HRQOL assessment in clinical practice. However, new technologies using computer adaptive testing and item response theory may allow those questionnaires to be quickly and more efficiently administered by clinic staff. The finding of different HRQOL scores among CKD patients of different racial and ethnic backgrounds supports the need to individualize the concept of HRQOL, so that we can assess the crucial aspects of life in our patients and integrate these domains into a comprehensive plan of care. These recent findings underline the critical need to measure HRQOL and to expand the boundaries of our multidimensional tools with technology and a more patient centered concept of quality of life.

Entities:  

Mesh:

Year:  2005        PMID: 16142573     DOI: 10.1007/s11255-004-0012-4

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  50 in total

Review 1.  Assessing health and quality of life outcomes in dialysis: a report on an Institute of Medicine workshop.

Authors:  R A Rettig; J H Sadler; K B Meyer; J H Wasson; G R Parkerson; B Kantz; R D Hays; D L Patrick
Journal:  Am J Kidney Dis       Date:  1997-07       Impact factor: 8.860

2.  Validation of questionnaires to estimate physical activity and functioning in end-stage renal disease.

Authors:  K L Johansen; P Painter; J A Kent-Braun; A V Ng; S Carey; M Da Silva; G M Chertow
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

3.  Developing a health-related quality-of-life measure for end-stage renal disease: The CHOICE Health Experience Questionnaire.

Authors:  A W Wu; N E Fink; K A Cagney; E B Bass; H R Rubin; K B Meyer; J H Sadler; N R Powe
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

4.  Psychosocial factors in adult end-stage renal disease patients treated with hemodialysis: correlates and outcomes.

Authors:  P L Kimmel
Journal:  Am J Kidney Dis       Date:  2000-04       Impact factor: 8.860

5.  Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Antonio Alberto Lopes; Jennifer L Bragg-Gresham; Sudtida Satayathum; Keith McCullough; Trinh Pifer; David A Goodkin; Donna L Mapes; Eric W Young; Robert A Wolfe; Philip J Held; Friedrich K Port
Journal:  Am J Kidney Dis       Date:  2003-03       Impact factor: 8.860

6.  Adjustment for comorbidity in studies on health status in ESRD patients: which comorbidity index to use?

Authors:  Jeannette G Van Manen; Johanna C Korevaar; Friedo W Dekker; Elisabeth W Boeschoten; Patrick M M Bossuyt; Raymond T Krediet
Journal:  J Am Soc Nephrol       Date:  2003-02       Impact factor: 10.121

7.  Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients.

Authors:  Edmund G Lowrie; Roberta Braun Curtin; Nancy LePain; Dorian Schatell
Journal:  Am J Kidney Dis       Date:  2003-06       Impact factor: 8.860

8.  Pathobiology and functional status of long-term hemodialysis patients.

Authors:  O Ifudu; W F Brezsnyak; C Reydel; E McClendon; T Surgrue; R DiRienzo; M M Avram; E A Friedman
Journal:  Am J Nephrol       Date:  1995       Impact factor: 3.754

9.  Characterizing sleep disorders in chronic hemodialysis patients.

Authors:  J L Holley; S Nespor; R Rault
Journal:  ASAIO Trans       Date:  1991 Jul-Sep

10.  Quality of life after kidney transplantation. A prospective, randomized comparison of cyclosporine and conventional immunosuppressive therapy.

Authors:  R G Simmons; L Abress; C R Anderson
Journal:  Transplantation       Date:  1988-02       Impact factor: 4.939

View more
  42 in total

1.  Dietary egg whites for phosphorus control in maintenance haemodialysis patients: a pilot study.

Authors:  Lynn M Taylor; Kamyar Kalantar-Zadeh; Theodore Markewich; Sara Colman; Debbie Benner; John J Sim; Csaba P Kovesdy
Journal:  J Ren Care       Date:  2011-03

2.  Thyroid Status, Quality of Life, and Mental Health in Patients on Hemodialysis.

Authors:  Connie M Rhee; Yanjun Chen; Amy S You; Steven M Brunelli; Csaba P Kovesdy; Matthew J Budoff; Gregory A Brent; Kamyar Kalantar-Zadeh; Danh V Nguyen
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-13       Impact factor: 8.237

3.  Design and rationale of health-related quality of life and patient-reported outcomes assessment in the Frequent Hemodialysis Network trials.

Authors:  Manisha Jhamb; Manjula K Tamura; Jennifer Gassman; Amit X Garg; Robert M Lindsay; Rita S Suri; George Ting; Fredric O Finkelstein; Scott Beach; Paul L Kimmel; Mark Unruh
Journal:  Blood Purif       Date:  2011-01-10       Impact factor: 2.614

Review 4.  Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney disease.

Authors:  Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Elani Streja; Connie M Rhee; Melissa Soohoo; Joline L T Chen; Miklos Z Molnar; Yoshitsugu Obi; Daniel Gillen; Danh V Nguyen; Keith C Norris; John J Sim; Steve S Jacobsen
Journal:  Nephrol Dial Transplant       Date:  2017-04-01       Impact factor: 5.992

Review 5.  Health-related quality of life in hypertension, chronic kidney disease, and coexistent chronic health conditions.

Authors:  Ritu K Soni; Anna C Porter; James P Lash; Mark L Unruh
Journal:  Adv Chronic Kidney Dis       Date:  2010-07       Impact factor: 3.620

6.  Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study.

Authors:  Mehdi Rambod; Rachelle Bross; Jennifer Zitterkoph; Deborah Benner; Juhi Pithia; Sara Colman; Csaba P Kovesdy; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2008-12-13       Impact factor: 8.860

Review 7.  Measuring patient experience in dialysis: a new paradigm of quality assessment.

Authors:  Connie M Rhee; Steven M Brunelli; Lalita Subramanian; Francesca Tentori
Journal:  J Nephrol       Date:  2017-04-21       Impact factor: 3.902

8.  The effects of kidney-disease-related loss on long-term dialysis patients' depression and quality of life: positive affect as a mediator.

Authors:  Ramony Chan; Robert Brooks; Jonathan Erlich; Josephine Chow; Michael Suranyi
Journal:  Clin J Am Soc Nephrol       Date:  2008-11-05       Impact factor: 8.237

Review 9.  Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors.

Authors:  Manisha Jhamb; Steven D Weisbord; Jennifer L Steel; Mark Unruh
Journal:  Am J Kidney Dis       Date:  2008-06-24       Impact factor: 8.860

10.  Quality of life and mortality from a nephrologist's view: a prospective observational study.

Authors:  Seung Seok Han; Ki Woong Kim; Ki Young Na; Dong-Wan Chae; Yon Su Kim; Suhnggwon Kim; Ho Jun Chin
Journal:  BMC Nephrol       Date:  2009-11-24       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.